GlassScriptPhysician profile
Justin William Ady
NPI 1558664599
$16,109.90
in general payments reported to CMS, 2019-2025
29 companies · $3,245 in 2025
The $3,245 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,251 · 2020: $1,323 · 2021: $2,651 · 2022: $3,161 · 2023: $2,036 · 2024: $1,443 · 2025: $3,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,724.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $5,839.34 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Gelweave |
| Medtronic, INC. | $2,117.46 | 2021-2025 | Ellipsys Vascular Access System, Endurant Iis, Hawkone |
| Silk Road Medical, INC. | $1,926.34 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $1,315.58 | 2021-2025 | General - Angioplasty, General - Thrombectomy, General - Vascular Intervention |
| W. L. Gore & Associates, INC. | $460.94 | 2021-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic Vascular, INC. | $438.31 | 2019-2020 | |
| Cook Medical LLC | $435.69 | 2020-2025 | Zenith Alpha |
| Organogenesis INC. | $433.27 | 2020-2024 | |
| Bard Peripheral Vascular, INC. | $431.15 | 2019-2025 | Crosser Iq |
| Shockwave Medical, INC | $402.94 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $382.38 | 2019-2021 | |
| Stryker Corporation | $331.67 | 2025 | Limflow System, Artix Mt |
| Kerecis Limited | $319.96 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Cardiovascular Systems INC. | $244.86 | 2019-2021 | |
| Inari Medical, INC. | $158.72 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $138.49 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Integra Lifesciences Corporation | $133.88 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Penumbra, INC. | $122.97 | 2021 | |
| Endologix LLC | $97.81 | 2021-2024 | Torus Stent Graft System, Endocross Device |
| Smith+Nephew, INC. | $90.14 | 2019-2023 | Collagenase Santyl, Regranex |
| Abbott Laboratories | $69.34 | 2023-2024 | Esprit, Jeti |
| Lemaitre Vascular, INC. | $63.00 | 2022-2023 | Hydro Lemaitre Valvulotome, Restoreflow |
| Argon Medical Devices, INC. | $30.19 | 2025 | Clot Management |
| Imperative Care, INC | $30.00 | 2025 | Prodigy Catheter |
| Acera Surgical, INC. | $27.07 | 2024 | Restrata Wound Matrix |
| Convatec INC. | $20.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.13 | 2024 | Xarelto |
| Cvrx, INC. | $16.80 | 2025 | Barostim Neo System |
| Cashflow Solutions, LLC | $11.61 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Ady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.